New patent for Amneal drug LYVISPAH

   June 16, 2023    Comments Off on New patent for Amneal drug LYVISPAH    Posted in: Patent Added

Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are two patents protecting…

The post New patent for Amneal drug LYVISPAH appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog